Todd Korthuis
Program Director, Addiction Medicine Fellowship · Oregon Health & Science University
Credentials: · · · · ·
History
- Present
Addiction Medicine Fellowship · Oregon Health & Science University
- Present
Addiction Medicine Section · Oregon Health & Science University
- 1998–1999
Addiction Medicine
1996–1998- 1991–1992
Naval Medical Center
1987–1991- 1982–1986
Research
PLoS ONE · 2013 · 1,150 citations
The major genetic determinants of HIV-1 control affect HLA class I peptide presentation
Science · 2010 · 997 citations
Cumulative Incidence of Cancer Among Persons With HIV in North America: A Cohort Study
Annals of Internal Medicine · 2015 · 269 citations
- RM
48 papers
- SS
35 papers

32 papers
- MB
31 papers

27 papers · 18 as a fellow
- VS
26 papers

24 papers

23 papers
Grants
- 2002–2032
Western States Node of the National Drug Abuse Treatment Clinical Trials Network (CTN-0149)
National Institute on Drug Abuse · UG1
Contact PI · $19.4M · Oregon Health & Science University
- 2026–2030
Psilocybin Research and Implementation Study for Mental Health and Substance Use (PRISM)
National Institute on Drug Abuse · R01
Contact PI · $736.7K · Oregon Health & Science University
- 2024–2029
Vanderbilt Oregon COllaborative Scholar Training in Addiction Research (COSTAR)
National Institute on Drug Abuse · K12
PI · $1.5M · Vanderbilt University Medical Center
- 2026–2028
The Safety and Clinical Outcomes of Psychedelic Use (SCOPE) Center
National Institute on Drug Abuse · U54
Contact PI · $1.4M · Oregon Health & Science University
Clinical trials
- 2015–2019
Buprenorphine to Improve HIV Care Engagement and Outcomes
Principal investigator · Completed · Phase 4
Oregon Health and Science University
- 2014–2015
Principal investigator · Completed · Phase 3
Oregon Health and Science University
- 2013–2015
Risky Decision Making in Methamphetamine Users: The Role of Opioid Blockade
Principal investigator · Completed
Oregon Health and Science University


